Skip to content
20-F/A

Annual Report (Foreign)

Altamira Therapeutics Ltd. CYTOF

0001213900-24-057548

← back to feed
Filed
Jul 1, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Dec 31, 2023 1.48M sh